IL-33 activates B1 cells and exacerbates contact sensitivity.

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• B1 B cells are vital for innate immunity, producing natural IgM, and are implicated in autoimmune diseases.
• The mechanisms governing B1 cell activation and proliferation are not fully understood.
• Interleukin-33 (IL-33) is a cytokine belonging to the IL-1 family with known immune regulatory functions.

Purpose of the Study:

• To investigate the role of IL-33 in the activation and function of B1 cells.
• To elucidate the mechanism by which IL-33 influences B1 cell proliferation and cytokine production.
• To determine the involvement of IL-33 and its receptor ST2 in delayed-type hypersensitivity.

Main Methods:

• In vitro and in vivo experiments using B1 cells and ST2-expressing cells.
• Assessment of B1 cell proliferation, IgM, IL-5, and IL-13 production.
• Utilized ST2-deficient mice and wild-type mice in contact sensitivity models.
• Adoptive transfer experiments to assess the functional capacity of IL-33-activated B1 cells.

Main Results:

• IL-33 significantly promotes B1 cell proliferation and enhances the production of IgM, IL-5, and IL-13 in a ST2-dependent manner.
• IL-33-induced B1 cell activity is partially dependent on T cells and mast cells and can be modulated by IL-5 neutralization.
• ST2-deficient mice exhibit reduced severity of oxazolone-induced contact sensitivity compared to wild-type mice.
• IL-33 exacerbates contact sensitivity in wild-type mice by enhancing B1 cell proliferation and IL-5 production.

Conclusions:

• IL-33 is a novel activator of B1 cells through its receptor ST2, influencing their proliferation and cytokine output.
• IL-33-activated B1 cells contribute to the pathogenesis of delayed-type hypersensitivity.
• This study uncovers a previously unrecognized pathway for B1 cell activation and implicates IL-33 in hypersensitivity reactions.